Scientists at IBM and the CHDI Foundation have used artificial intelligence to analyse datasets from Huntington’s disease observational trials to model progression of the disease. They hope their findings will help improve clinical trial design.
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can't promise to write content about any particular suggestion.
